Search

Displaying results 4161 - 4170 of 10000 in total
  1. Drug

    Trehalose-6-Phosphate

    go.drugbank.com/drugs/DB02430
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    Lonidamine

    go.drugbank.com/drugs/DB06266
    Investigational

    Lonidamine (LND) is a drug that interferes with energy metabolism of cancer cells, principally inhibiting aerobic glycolytic activity, by its effect on mitochondrially-bound hexokinase (HK). … In such way LND could impair energy-requiring processes, as recovery from potentially lethal damage, induced by radiation treatment and by some cytotoxic drugs.

  3. Drug

    Zinc carbonate

    go.drugbank.com/drugs/DB14494
    Investigational

    Mixtures: Ma Ying Long Hemorrhoidal
  4. Drug

    Osemozotan

    go.drugbank.com/drugs/DB05339
    Experimental

    MN-305 is a novel, potent and highly selective serotonin 5-HT1A receptor agonist under development by MediciNova for the treatment of anxiety disorders beginning with Generalized Anxiety Disorder (GAD)

  5. Drug

    Calcium sulfate

    go.drugbank.com/drugs/DB15533
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Troclosene

    go.drugbank.com/drugs/DB15960
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    1,2-Hexanediol

    go.drugbank.com/drugs/DB14108
    Investigational

    Synonyms: DL-1,2-Hexanediol, DL-Hexane-1,2-diolMixtures: Anbiser B-HA HYALURONIC ACID MOISTURIZING
  8. Drug

    4-nitrophenyl-beta-D-galactoside

    go.drugbank.com/drugs/DB02632
    Experimental

    Categories: Compounds used in a research, industrial, or household settingSynonyms: 1-O-(4-nitrophenyl)-β-D-galactose, 4-nitrophenyl-β-D-galactoside
  9. Drug

    T-5224

    go.drugbank.com/drugs/DB05998
    Experimental

    T-5224 is an investigational drug developed to treat Sepsis-induced Acute Kidney Injury. It's mechanism of action is to inhibit c-Fos/activator protein-1.

  10. Drug

    Corticorelin

    go.drugbank.com/drugs/DB05394
    Investigational

    Corticotropin-releasing factor is studied in the treatment of brain cancer. It is made naturally by the hypothalamus (a part of the brain) and can also be made in the laboratory. … It is a type of neurohormone, also called hCRF.